论文部分内容阅读
非ST段抬高心肌梗死(NSTEM I)系急性冠脉综合征(ACS)的重要组成成分,是由易损性粥样硬化斑块破裂伴随血小板聚集、血栓形成,导致冠脉血流减少从而引起急性、亚急性心肌缺血而引发的一种临床综合征[1-2]。我们在常规采用单硝酸异山梨酯注射液等治疗的基础上加用奥扎格雷钠治疗非
Non-ST-segment elevation myocardial infarction (NSTEMI) is an important component of acute coronary syndrome (ACS), which is caused by the rupture of vulnerable atherosclerotic plaque accompanied by platelet aggregation and thrombosis leading to decreased coronary blood flow Acute, subacute myocardial ischemia caused by a clinical syndrome [1-2]. We are in the conventional use of isosorbide mononitrate injection on the basis of treatment plus sodium ozagrel treatment of non